← Eichor
Study identifier: NCT06705075 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Evaluation of Uterine Fibroids by CEUS and SHAPE Pre and Post UAE

Condition: Uterine Fibroid  ·  Sponsor: Thomas Jefferson University

PhasePhase 2
Planned participants80
Who can joinFemale, 18 Years to no upper limit
Healthy volunteersNo

About this study

This study goals are to determine the patterns of uterine fibroid vascularity pre and post UAE using CEUS resulting in an alternative to gadolinium-enhanced MRI that is less expensive, has less contra-indications and side effects, is real time, and noninvasive helping physicians to evaluate the result of UAE procedures. Also, this study will evaluate uterine fibroid pressures using SHAPE, comparing the results with normal myometrium tissue in order to determine its characteristics and tissue differences, which we believe will lead to the development of a new biomarker for the diagnosis and treatment of uterine fibroids.

This description comes directly from the study's public registry record.

Talk to the study team

Priscilla Machado, MD  ·  215-955-4279  ·  priscilla.machado@jefferson.edu

Always discuss trial participation with your own doctor first.

Locations (1)

Thomas Jefferson UniversityPhiladelphia, Pennsylvania, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06705075